Document is current

Article History

Received: 14 May 2024

Accepted: 25 September 2024

First Online: 4 October 2024

Declarations

:

: Not applicable.

: Not applicable.

: DG-K has received travel support from CSL Behring and honoraria from Bio Products Laboratory, CSL Behring, and Takeda Pharmaceuticals for prior presentations and videos. CA has received honoraria from CSL Behring and Takeda for prior presentations. CK has received honoraria from CSL Behring and Takeda for prior presentations and advisory boards. PKK has been a speaker, advisory board member, or consultant for, and has received honoraria from, ALK, AstraZeneca, Bausch, BioCryst, Canadian Agency for Drugs and Technologies in Health, Canadian Pharmacists Association, CSL Behring, GSK, Medexus, Merck, Novartis, Sanofi Genzyme, Takeda/Shire, and Valeo Pharma, has received research grants from CSL Behring and Takeda/Shire, serves as a medical adviser (volunteer) for Hereditary Angioedema Canada (a patient organization), serves as a board member (volunteer) for the Canadian Hereditary Angioedema Network (a physician organization), and is an employee of McMaster University.